Manhattan Drug Company
- Company typePrivate
- Founded1974
- HeadquartersHillside, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Manhattan Drug Company firmographics
Firmographics- Name
- Manhattan Drug Company
- Legal name
- Manhattan Drug Company, Inc.
- Website
- https://manhattandrug.com
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Manhattan Drug Company industry classification
Industry- Product category
- Contract Manufacturing of Dietary Supplements
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where Manhattan Drug Company is headquartered
LocationHeadquarters
- HQ city
- Hillside
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Manhattan Drug Company business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Revenue generated from providing custom tablet and capsule manufacturing services to dietary supplement companies. Services include blending, compressing, coating, encapsulation, packaging, and warehousing/fulfillment. Pricing is quote-based depending on formulation, volume, and service requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom manufacturing quote-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Manhattan Drug Company product offering
Product offeringCore offering
Manhattan Drug Company provides B2B contract manufacturing services for solid dose dietary supplements, including custom blending, compressing, coating, encapsulation, and packaging of tablets and capsules in NSF certified facilities. The company offers in-house analytical and microbiology testing, formulation assistance, regulatory documentation support (Kosher, Halal, international registration), and warehousing/fulfillment services to dietary supplement brand companies.
Product overview
Manhattan Drug Company (MDC) operates as a manufacturing source for solid dose dietary supplements, offering custom tablet and capsule manufacturing services. The company provides an integrated suite of manufacturing capabilities including blending, compressing, coating, encapsulation, and packaging, along with warehousing and fulfillment services. Their Custom Tablet and Capsule Manufacturing service forms the core of their offering, supported by in-house analytical and microbiology laboratories for quality, efficacy, and safety testing.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Tablet and Capsule Manufacturing
- Analytical and Microbiology Quality Testing In-house analytical and microbiology laboratory services providing quality, efficacy, and safety testing for dietary supplement products, supporting contract manufacturing customers in meeting quality and regulatory requirements.
- Warehousing and Fulfillment Services Warehousing and fulfillment services provided to dietary supplement customers following manufacturing, enabling integrated supply chain support from production through distribution.
- Formulation and Regulatory Compliance Assistance Assistance with product formulation (or use of customer-supplied formulas) and preparation of regulatory documentation for product registration abroad and certification with bodies such as Kosher and Halal.
Companies that use Manhattan Drug Company
Customer profileSegments1 record
Ideal customer profiles1 record
Manhattan Drug Company technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Manhattan Drug Company partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Integrated Biopharma, Inc.coreManhattan Drug Company, Inc. is a wholly-owned subsidiary of Integrated Biopharma, Inc. (NASDAQ: IBPH). This is a parent-subsidiary relationship where Manhattan Drug Company operates as part of the Integrated Biopharma corporate structure.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Manhattan Drug Company competitors and assessment
Company assessmentDirect peers
- Best Formulations: Best Formulations is a contract manufacturer of vitamins, supplements, and over-the-counter health products, offering custom tablet, capsule, and softgel manufacturing plus packaging services. Directly comparable to MDC as a mid-sized nutraceutical CDMO serving dietary supplement brands with end-to-end formulation-to-fulfillment services.
- NutraScience Labs: NutraScience Labs is a contract manufacturer specializing in custom dietary supplement manufacturing, including tablets, capsules, powders, and liquids for emerging and established supplement brands. Directly comparable to MDC in the nutraceutical contract manufacturing niche.
- ABH Pharma: ABH Pharma provides contract manufacturing services for nutritional supplements, OTC drugs, and personal care products, including tablet and capsule production. Comparable to MDC as a mid-sized CDMO focused on supplement and OTC product manufacturing.
- Robinson Pharma: Robinson Pharma is one of the largest U.S. contract manufacturers of dietary supplements, producing tablets, capsules, softgels, and powders for supplement brands. Directly comparable to MDC in offering custom solid-dose manufacturing services to supplement companies, though at significantly larger scale.
- International Vitamin Corporation (IVC): IVC manufactures vitamins, minerals, and dietary supplements on a contract basis, including tablets, capsules, and gummies. Comparable to MDC as a custom contract manufacturer in the solid-dose supplement category.
Broad incumbents
- Catalent: Catalent is a global CDMO serving pharmaceutical and consumer health companies with broad dosage form capabilities including softgels, tablets, and capsules. Comparable to MDC as a contract manufacturer in the nutraceutical/consumer health space, though much larger and with a broader therapeutic focus.
- Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon business is a leading global CDMO offering comprehensive pharmaceutical development and manufacturing services. Comparable to MDC as a contract manufacturer serving health product companies, though at vastly larger scale and with broader capabilities including biologics.
- Pharmavite: Pharmavite is a vertically integrated manufacturer of vitamin and supplement brands (Nature Made, MegaFood). While primarily a brand owner, it also operates significant contract manufacturing capacity for solid-dose supplements, making it a comparable capability benchmark for MDC.
Emerging players
- CapsCanada: CapsCanada is a North American manufacturer specializing in capsule production (both empty capsules and contract encapsulation services). Comparable to MDC in the solid-dose supplement manufacturing space, though narrower in scope as a capsule-focused specialist.
- Vitakem: Vitakem is a custom contract manufacturer of dietary supplements and nutraceuticals offering tablet, capsule, and powder manufacturing services. Comparable to MDC as a mid-sized CDMO focused on the nutraceutical supplement category.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Customer concentration
Manhattan Drug Company social profiles
Digital presenceManhattan Drug Company compliance and trust
Trust signalCompliance1 record
Manhattan Drug Company financial estimates
Financial estimateRevenue estimate
Valuation estimate
Manhattan Drug Company leadership team
Management profileNumber of profiles
Manhattan Drug Company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Manhattan Drug Company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Manhattan Drug Company
What does Manhattan Drug Company do?
Manhattan Drug Company provides B2B contract manufacturing services for solid dose dietary supplements, including custom blending, compressing, coating, encapsulation, and packaging of tablets and capsules in NSF certified facilities. The company offers in-house analytical and microbiology testing, formulation assistance, regulatory documentation support (Kosher, Halal, international registration), and warehousing/fulfillment services to dietary supplement brand companies.
Is Manhattan Drug Company a public or private company?
Manhattan Drug Company is a private company. It is classified as corporate owned and is currently operating.
When was Manhattan Drug Company founded?
Manhattan Drug Company was founded in 1974. It employs 51 to 100 people.
Where is Manhattan Drug Company based?
Manhattan Drug Company is headquartered in Hillside, United States, in the North America region.
How does Manhattan Drug Company make money?
One revenue line is on record: contract Manufacturing Services.
Who are Manhattan Drug Company's main competitors?
Direct peers on record are Best Formulations, NutraScience Labs, ABH Pharma, Robinson Pharma and International Vitamin Corporation (IVC). Broad incumbents are Catalent, Thermo Fisher Scientific (Patheon) and Pharmavite. Emerging players are CapsCanada and Vitakem.
Does Manhattan Drug Company have an API?
No public API is recorded for Manhattan Drug Company.
What industry is Manhattan Drug Company in?
Manhattan Drug Company's product category is Contract Manufacturing of Dietary Supplements. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.